Stock Track | Evolent Health Plummets 5% as Oppenheimer Slashes Price Target

Stock Track11-12

Shares of Evolent Health (EVH) plummeted 5.06% during Wednesday's intraday trading session, reflecting investor concern over the company's near-term prospects. The significant drop came as the healthcare company faced a notable revision in analyst expectations.

The catalyst for the sell-off appears to be Oppenheimer's decision to lower its price target on Evolent Health to $12 from $18, a substantial 33% reduction. Despite maintaining an Outperform rating on the stock, the dramatic cut in the price target suggests the firm has tempered its outlook for Evolent Health's future performance. This adjustment follows the company's recent quarterly results, indicating potential challenges in meeting previous growth expectations. While the full details of Oppenheimer's analysis were not provided, such a significant reduction in price target often prompts investors to reassess their positions, leading to increased selling pressure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1168779318?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 23:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168779318","market":"us","top_or_hot":-1,"title":"Stock Track | Evolent Health Plummets 5% as Oppenheimer Slashes Price Target","media":"Stock Track","content":"<p>Shares of Evolent Health (EVH) plummeted 5.06% during Wednesday's intraday trading session, reflecting investor concern over the company's near-term prospects. The significant drop came as the healthcare company faced a notable revision in analyst expectations.</p>\n\n<p>The catalyst for the sell-off appears to be Oppenheimer's decision to lower its price target on Evolent Health to $12 from $18, a substantial 33% reduction. Despite maintaining an Outperform rating on the stock, the dramatic cut in the price target suggests the firm has tempered its outlook for Evolent Health's future performance. This adjustment follows the company's recent quarterly results, indicating potential challenges in meeting previous growth expectations. While the full details of Oppenheimer's analysis were not provided, such a significant reduction in price target often prompts investors to reassess their positions, leading to increased selling pressure.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Evolent Health Plummets 5% as Oppenheimer Slashes Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Evolent Health Plummets 5% as Oppenheimer Slashes Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-12 23:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Evolent Health (EVH) plummeted 5.06% during Wednesday's intraday trading session, reflecting investor concern over the company's near-term prospects. The significant drop came as the healthcare company faced a notable revision in analyst expectations.</p>\n\n<p>The catalyst for the sell-off appears to be Oppenheimer's decision to lower its price target on Evolent Health to $12 from $18, a substantial 33% reduction. Despite maintaining an Outperform rating on the stock, the dramatic cut in the price target suggests the firm has tempered its outlook for Evolent Health's future performance. This adjustment follows the company's recent quarterly results, indicating potential challenges in meeting previous growth expectations. While the full details of Oppenheimer's analysis were not provided, such a significant reduction in price target often prompts investors to reassess their positions, leading to increased selling pressure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EVH","symbol_name":"Evolent Health Inc","start_time":0,"source_url":"","article_id":"1168779318","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168779318","pubTimestamp":1762961422,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Evolent Health (EVH) plummeted 5.06% during Wednesday's intraday trading session, reflecting investor concern over the company's near-term prospects. The significant drop came as the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EVH":"Evolent Health Inc"},"translate_title":"股票追踪|奥本海默大幅下调目标价，Evolent Health暴跌5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVH":1},"content_text":"Shares of Evolent Health (EVH) plummeted 5.06% during Wednesday's intraday trading session, reflecting investor concern over the company's near-term prospects. The significant drop came as the healthcare company faced a notable revision in analyst expectations.\nThe catalyst for the sell-off appears to be Oppenheimer's decision to lower its price target on Evolent Health to $12 from $18, a substantial 33% reduction. Despite maintaining an Outperform rating on the stock, the dramatic cut in the price target suggests the firm has tempered its outlook for Evolent Health's future performance. This adjustment follows the company's recent quarterly results, indicating potential challenges in meeting previous growth expectations. While the full details of Oppenheimer's analysis were not provided, such a significant reduction in price target often prompts investors to reassess their positions, leading to increased selling pressure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1168779318","isCrawlerRequest":true}